World's Best Scientists 2026 revealed!
Amelia Ruffatti

Amelia Ruffatti

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
9035
World Ranking
17204
National Ranking
545

Amelia Ruffatti publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Amelia Ruffatti sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 173 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Amelia Ruffatti D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Amelia Ruffatti sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 51 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Amelia Ruffatti is affiliated with the University of Padua in Italy and has contributed extensively to the field of Medicine, with a particular focus on Rheumatology, Hematology, Genetics, Immunology, and Surgery. Their research primarily explores systemic autoimmune disorders, blood-related diseases, and immune mechanisms.

The topics addressed in Ruffatti's work include:

  • Systemic Lupus Erythematosus Research
  • Blood disorders and treatments
  • Platelet Disorders and Treatments
  • Blood Coagulation and Thrombosis Mechanisms
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Immunodeficiency and Autoimmune Disorders
  • Complement system in diseases

Ruffatti has published research in various medical journals, with frequent appearances in:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Seminars in Arthritis and Rheumatism
  • Autoimmunity Reviews
  • Blood

Notable recent papers include:

  • The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus (2020, Autoimmunity Reviews)
  • The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies (2020, Seminars in Arthritis and Rheumatism)
  • Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome (2021, Blood)
  • The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics (2020, Archives of Gynecology and Obstetrics)
  • High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets (2021, Clinical and Experimental Rheumatology)

Ruffatti frequently collaborates with a number of coauthors in their research endeavors. Some of the most recurrent collaborators are:

  • Marta Tonello
  • Ariela Hoxha
  • Maria Favarò
  • Teresa Del Ross
  • Antonia Calligaro

The scientist's research interests intersect multiple subfields, reflecting a multidisciplinary approach to understanding complex autoimmune and hematological diseases. Their work often examines the mechanisms of blood coagulation, platelet function, and immune system abnormalities, particularly in conditions such as antiphospholipid syndrome and related disorders.

Best Publications

  • Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

    Vittorio Pengo;Amelia Ruffatti;C Legnani;P Gresele

  • Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

    Vittorio Pengo;Amelia Ruffatti;Cristina Legnani;Sophie Testa

  • The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study.

    B. De Laat;V. Pengo;I. Pabinger;J. Musial

  • Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study

    Amelia Ruffatti;Teresa Del Ross;Manuela Ciprian;Maria T Bertero

  • Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.

    Gabriele Saccone;Vincenzo Berghella;Giuseppe Maria Maruotti;Tullio Ghi

  • Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis

    Laurent Arnaud;Laurent Arnaud;Alexis Mathian;Amelia Ruffatti;Doruk Erkan

  • Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity

    Amelia Ruffatti;Marta Tonello;Teresa Del Ross;Anna Cavazzana

  • The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study.

    Arsène Mekinian;Maria Grazia Lazzaroni;Anna Kuzenko;Jaume Alijotas-Reig

  • Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies

    Vittorio Pengo;A Biasiolo;T Brocco;S Tonetto

  • The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases

    Jaume Alijotas-Reig;Raquel Ferrer-Oliveras;Amelia Ruffatti;Angela Tincani

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  • Pregnancy, cytokines, and disease activity in systemic lupus erythematosus

    Andrea Doria;Anna Ghirardello;Luca Iaccarino;Sandra Zampieri

  • Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.

    Laurent Arnaud;Laurent Arnaud;Alexis Mathian;Hervé Devilliers;Amelia Ruffatti

  • Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification.

    A. Ruffatti;S. Olivieri;M. Tonello;M. Bortolati

  • Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome

    Entela Nuri;Mara Taraborelli;Laura Andreoli;Marta Tonello

  • Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.

    Vittorio Pengo;Amelia Ruffatti;T. Del Ross;Marta Tonello

  • Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study.

    N Bizzaro;Anna Ghirardello;S Zampieri;Luca Iaccarino

  • Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies.

    T. Marchetti;A. Ruffatti;C. Wuillemin;P. de Moerloose

  • Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

    A. Banzato;N. Pozzi;R. Frasson;V. De Filippis

  • Autoantibodies of Systemic Rheumatic Diseases in the Healthy Elderly

    Amelia Ruffatti;Laura Rossi;Antonia Calligaro;Teresa Del Ross

Frequent Co-Authors

Vittorio Pengo
Vittorio Pengo University of Padua
Leonardo Punzi
Leonardo Punzi University of Padua
Angela Tincani
Angela Tincani University of Brescia
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Andrea Doria
Andrea Doria University of Padua
Anna Ghirardello
Anna Ghirardello University of Padua
Ricard Cervera
Ricard Cervera University of Barcelona
Patrizia Rovere-Querini
Patrizia Rovere-Querini Vita-Salute San Raffaele University
Nathalie Costedoat-Chalumeau
Nathalie Costedoat-Chalumeau Université Paris Cité
Paolo Gresele
Paolo Gresele University of Perugia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Graduates in Biology and Biochemistry are finding new opportunities through online education pathways. For those interested in the health field, a popular choice is medical coding. Many prospective students ask, how long does it take to become a medical coder? The answer depends on your commitment, but certificate programs can often be completed in less than a year.

Another career path worth considering is medical billing and coding. Wondering is medical billing and coding worth it? The field offers stability and flexible work options, especially for those who prefer remote or part-time roles.

For students seeking broader roles in healthcare, many are exploring health information management schools online. These degrees can lead to administrative or technology-focused positions in health services.

Nutrition is also a growing field. There are several programs for those seeking advancement, and you can save money by considering the cheapest online master's in nutrition. These programs open doors to roles in wellness coaching, food science, and public health.

Best Scientists Citing Amelia Ruffatti

Trending Scientists

Recently Published Articles